Theravance Biopharma buy melinda
Start price
03.08.17
/
50%
€32.04
Target price
26.12.17
€42.00
Performance (%)
-13.61%
End price
26.12.17
€27.68
Summary
This prediction ended on 26.12.17 with a price of €27.68. The prediction for Theravance Biopharma disappointed with a performance of -13.61%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Theravance Biopharma | -1.274% | -1.274% | 78.161% | 46.226% |
| iShares Core DAX® | 2.462% | 4.579% | 23.150% | 68.407% |
| iShares Nasdaq 100 | 1.237% | -0.442% | 7.600% | 114.213% |
| iShares Nikkei 225® | 2.933% | 1.229% | 16.068% | 51.681% |
| iShares S&P 500 | 0.975% | 0.565% | 4.794% | 67.782% |
Comments by melinda for this prediction
In the thread Theravance Biopharma diskutieren
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Theravance Biopharma
Theravance Biopharma
Start price
Target price
Perf. (%)
€22.20
11.03.20
11.03.20
€25.00
21.08.20
21.08.20
-29.73%
21.08.20
21.08.20
Theravance Biopharma
Start price
Target price
Perf. (%)
€25.38
10.02.18
10.02.18
€32.11
13.08.18
13.08.18
-0.43%
13.08.18
13.08.18
Theravance Biopharma
Start price
Target price
Perf. (%)
€28.90
03.08.17
03.08.17
€37.88
26.12.17
26.12.17
-13.61%
26.12.17
26.12.17


